Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.7K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.7K
Pneumonia IV: Management01:28

Pneumonia IV: Management

499
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
499
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

960
The pathophysiology of pneumonia involves the following steps:
960
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

523
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
523
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

395
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
395
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

710
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
710

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CCL17-neutralizing and esterase-responsive core-shell microgels for endogenous Tregs recruitment and functional enhancement in myocardial infarction.

Bioactive materials·2026
Same author

Ionic thermoelectrics goes epidermal theranostics.

National science review·2026
Same author

Theoretical quantitative model and clinical outcome predictions of conductive cardiac patches for electrophysiological treatments.

Nature biomedical engineering·2026
Same author

Thioketal-Based Polymers for Biomedical Applications: Structure Design, Properties, And Perspectives.

ACS macro letters·2026
Same author

Hydrogels for 3D-printed breast scaffolds on esthetic, functional, and oncological safety: A review.

Journal of applied biomaterials & functional materials·2026
Same author

Hardystonite bioceramic-endowed multifunctions of polylactic acid-based composites favourable for developing next-generation fixation implants.

Biomaterials science·2026

Related Experiment Video

Updated: Oct 15, 2025

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
07:43

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

Published on: September 28, 2016

9.2K

Inflammation-modulating nanoparticles for pneumonia therapy.

Wali Muhammad1, Zihe Zhai1, Shuqin Wang1

  • 1MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, China.

Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
|October 29, 2021
PubMed
Summary
This summary is machine-generated.

Nanoparticles can suppress lung inflammation and immune responses to effectively treat pneumonia and acute lung injury (ALI). This review summarizes pathological microenvironments and inflammation-modulating nanoparticles for advanced therapeutic strategies.

Keywords:
inflammation-modulating biomaterialslung injurynanoparticlespneumoniastimuli-responsive

More Related Videos

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.6K
P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

11.1K

Related Experiment Videos

Last Updated: Oct 15, 2025

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
07:43

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

Published on: September 28, 2016

9.2K
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.6K
P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

11.1K

Area of Science:

  • Nanomedicine
  • Biomaterials Science
  • Respiratory Medicine

Background:

  • Pneumonia is a leading cause of death, characterized by lung inflammation due to pathogens.
  • Current pharmacotherapies are effective, but advanced treatments are needed for complex cases like viral pneumonia and acute lung injury (ALI).
  • Inflammation modulation nanoparticles (NPs) show promise in suppressing immune cells and inflammatory molecules in the lungs.

Purpose of the Study:

  • To summarize the pathological inflammatory microenvironments in pneumonia.
  • To review inflammation-modulating nanoparticles (NPs) for pneumonia and ALI treatment.
  • To guide the design of biomaterial therapies for respiratory diseases.

Main Methods:

  • Review of existing literature on pneumonia pathology and inflammation.
  • Analysis of nanoparticle properties and their interaction with lung inflammatory pathways.
  • Focus on NPs that modulate inflammatory cells, cytokines, chemokines, and microenvironments.

Main Results:

  • Pathological inflammatory microenvironments in pneumonia provide insights for biomaterial design.
  • Inflammation-modulating NPs can effectively suppress immune responses and inflammatory mediators.
  • NPs offer a promising therapeutic approach for pneumonia and ALI.

Conclusions:

  • Understanding pneumonia's inflammatory microenvironment is crucial for developing effective therapies.
  • Inflammation-modulating nanoparticles represent a significant advancement in nanomedicine for respiratory diseases.
  • Biomaterial-based nanomedicine holds potential for improved treatment of pneumonia and ALI.